Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ann-Marie Patch
Affiliation
QIMR Berghofer Medical Research Institute
ORCID
Career Start Year
2005
Papers
82
H Index
39
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36938641
Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.
Cancer Cytopathol
2023
37927461
Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.
Front Oncol
2023
36938641
Evaluating Diff-Quik cytology smears for large-panel mutation testing in lung cancer-Predicting DNA content and success with low-malignant-cellularity samples.
Cancer Cytopathol
2023
36739348
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.
Leukemia
2023
37927461
Discrepancies in tumor mutation burden reporting from sequential endobronchial ultrasound transbronchial needle aspiration samples within single lymph node stations - brief report.
Front Oncol
2023
36739348
Cre recombinase expression cooperates with homozygous FLT3 internal tandem duplication knockin mouse model to induce acute myeloid leukemia.
Leukemia
2023
35012638
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
Genome Med
2022
35637530
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Genome Med
2022
35570070
Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.
Blood Rev
2022
35849877
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
ESMO Open
2022
36699384
qmotif: determination of telomere content from whole-genome sequence data.
Bioinform Adv
2022
36452869
Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis.
Cell Rep Methods
2022
35012638
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer.
Genome Med
2022
35637530
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma.
Genome Med
2022
35570070
Neoantigens - the next frontier in precision immunotherapy for B-cell lymphoproliferative disorders.
Blood Rev
2022
35849877
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.
ESMO Open
2022
36452869
Comparative analysis of Illumina Mouse Methylation BeadChip and reduced-representation bisulfite sequencing for routine DNA methylation analysis.
Cell Rep Methods
2022
36699384
qmotif: determination of telomere content from whole-genome sequence data.
Bioinform Adv
2022
33439897
Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.
PLoS Pathog
2021
34076666
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
JAMA Dermatol
2021
34162658
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.
Cancer Epidemiol Biomarkers Prev
2021
33439897
Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.
PLoS Pathog
2021
34076666
Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.
JAMA Dermatol
2021
34162658
Identification of a Locus Near <i>ULK1</i> Associated With Progression-Free Survival in Ovarian Cancer.
Cancer Epidemiol Biomarkers Prev
2021
32384699
<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.
Cancers (Basel)
2020
32414751
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.
Clin Cancer Res
2020
31935636
Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.
Neoplasia
2020
32384699
<i>APC</i> Mutation Marks an Aggressive Subtype of <i>BRAF</i> Mutant Colorectal Cancers.
Cancers (Basel)
2020
33067454
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.
Nat Commun
2020
33053644
The Impact of Next Generation Sequencing in Cancer Research.
Cancers (Basel)
2020
31935636
Alterations in signaling pathways that accompany spontaneous transition to malignancy in a mouse model of BRAF mutant microsatellite stable colorectal cancer.
Neoplasia
2020
33053644
The Impact of Next Generation Sequencing in Cancer Research.
Cancers (Basel)
2020
33067454
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity.
Nat Commun
2020
32414751
FGFR2c Mesenchymal Isoform Expression Is Associated with Poor Prognosis and Further Refines Risk Stratification within Endometrial Cancer Molecular Subtypes.
Clin Cancer Res
2020
30279471
Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.
Genet Med
2019
30446706
Correction: Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.
Genet Med
2019
30279471
Homozygosity mapping provides supporting evidence of pathogenicity in recessive Mendelian disease.
Genet Med
2019
30178487
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
Int J Cancer
2019
31090900
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Ann Oncol
2019
31464824
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Melanoma Res
2019
30736342
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.
Cancers (Basel)
2019
30954552
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Cell Mol Gastroenterol Hepatol
2019
30717762
Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
BMC Med Genomics
2019
31320640
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
Nat Commun
2019
30178487
Whole genome sequencing of melanomas in adolescent and young adults reveals distinct mutation landscapes and the potential role of germline variants in disease susceptibility.
Int J Cancer
2019
31464824
Evaluation of the contribution of germline variants in BRCA1 and BRCA2 to uveal and cutaneous melanoma.
Melanoma Res
2019
31320640
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets.
Nat Commun
2019
30954552
Integrative Genome-Scale DNA Methylation Analysis of a Large and Unselected Cohort Reveals 5 Distinct Subtypes of Colorectal Adenocarcinomas.
Cell Mol Gastroenterol Hepatol
2019
30736342
Intratumoural Heterogeneity Underlies Distinct Therapy Responses and Treatment Resistance in Glioblastoma.
Cancers (Basel)
2019
31090900
Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers.
Ann Oncol
2019
1 - 50 of 164
Column Actions
Search
Recommended Authors
Nayoung K D Kim
Samsung Genome Institute, Samsung Medical Center
Career Start Year
2013
Number of shared co-authors
2
Gordon Saksena
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2011
Number of shared co-authors
32
Emilie Lalonde
University of Pennsylvania
Career Start Year
2010
Number of shared co-authors
17
Ignaty Leshchiner
Broad Institute of Massachusetts Institute of Technology and Harvard
Career Start Year
2008
Number of shared co-authors
1
Hui Zhao
College of Life Sciences, University of Chinese Academy of Sciences
Career Start Year
2007
Number of shared co-authors
17
Alison Meynert
Institute of Genetics and Cancer, University of Edinburgh
Career Start Year
2006
Number of shared co-authors
14
David C Wedge
Manchester Cancer Research Centre, University of Manchester
Career Start Year
2006
Number of shared co-authors
30
Robert C Onofrio
The Broad Institute of Harvard and MIT
Career Start Year
2005
Number of shared co-authors
20
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year
2005
Number of shared co-authors
25
Chip Stewart
Broad Institute of MIT and Harvard
Career Start Year
2004
Number of shared co-authors
19
Olivier Harismendy
University of California
Career Start Year
2003
Number of shared co-authors
6
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2003
Number of shared co-authors
33
Michael D McLellan
McDonnell Genome Institute, Washington University in St. Louis
Career Start Year
2003
Number of shared co-authors
13
Peter Van Loo
The Francis Crick Institute
Career Start Year
2003
Number of shared co-authors
36
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year
2001
Number of shared co-authors
8
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year
2000
Number of shared co-authors
39
Yan W Asmann
Mayo Clinic
Career Start Year
2000
Number of shared co-authors
8
Michael N Edmonson
St. Jude Children's Research Hospital
Career Start Year
1999
Number of shared co-authors
7
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year
1999
Number of shared co-authors
9
Carrie Sougnez
The Broad Institute of Harvard and MIT
Career Start Year
1998
Number of shared co-authors
23
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year
1998
Number of shared co-authors
9
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1997
Number of shared co-authors
21
Sean McGrath
Harvard T.H. Chan School of Public Health
Career Start Year
1996
Number of shared co-authors
4
Tom Walsh
University of Washington
Career Start Year
1996
Number of shared co-authors
21
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
9
Robert S Fulton
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year
1994
Number of shared co-authors
20
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year
1992
Number of shared co-authors
42
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year
1991
Number of shared co-authors
48
Elaine R Mardis
The Ohio State University
Career Start Year
1988
Number of shared co-authors
32
Matthew Meyerson
Broad Institute
Career Start Year
1983
Number of shared co-authors
40
row(s) 1 - 30 of 30
Collaborators
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers
47
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers
41
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers
36
Sean M Grimmond
The University of Melbourne
Co-authored papers
23
Sian Ellard
Royal Devon University Healthcare NHS Foundation Trust
Co-authored papers
21
Andrew T Hattersley
Co-authored papers
19
J Lynn Fink
The University of Queensland Diamantina Institute, The University of Queensland
Co-authored papers
13
Karin S Kassahn
Adelaide Medical School, The University of Adelaide
Co-authored papers
12
Nicholas K Hayward
QIMR Berghofer Medical Research Institute
Co-authored papers
11
Amber L Johns
Garvan Institute of Medical Research and The Kinghorn Cancer Centre
Co-authored papers
10
Mark J Cowley
Children's Cancer Institute, Lowy Cancer Research Centre
Co-authored papers
9
Richard A Scolyer
Co-authored papers
8
Nikolajs Zeps
Queensland University of Technology
Co-authored papers
7
Peter T Simpson
UQ Centre for Clinical Research, The University of Queensland
Co-authored papers
7
Sunil R Lakhani
University of Queensland
Co-authored papers
6
Anna DeFazio
Westmead Hospital
Co-authored papers
6
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers
6
Sian Fereday
Peter MacCallum Cancer Centre
Co-authored papers
6
Yoke-Eng Chiew
Westmead Hospital
Co-authored papers
5
David A Wheeler
Baylor College of Medicine
Co-authored papers
5
Paul Harnett
Westmead Clinical School, University of Sydney
Co-authored papers
5
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers
5
Dariush Etemadmoghadam
Peter MacCallum Cancer Centre
Co-authored papers
5
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers
5
William A Robinson
National Centre for Asbestos Related Diseases, University of Western Australia
Co-authored papers
5
Joy Hendley
Peter MacCallum Cancer Centre
Co-authored papers
4
Richard A Gibbs
Baylor College of Medicine
Co-authored papers
4
Georgina V Long
Co-authored papers
4
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers
4
Jonathan Beesley
QIMR Berghofer Medical Research Institute
Co-authored papers
4
1 - 30